9 Multiple Myeloma Clinical Trials in Gilbert, AZ (2026)

Q: How do I join a clinical trial in Gilbert?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you.

Recruiting Multiple Myeloma Studies in Gilbert

NCT05552222Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) ...

Gilbert, AZPHASE31,590 participantsJanssen Research & Development, LLC

View Study Details

NCT00477100Recruiting

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

This trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer. Collecting medical data and storing sampl...

Gilbert, AZ1,200 participantsM.D. Anderson Cancer Center

View Study Details

NCT07391657Recruiting

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

This is a randomised, multicentre, controlled, open-label, Phase III global study comparing the efficacy and safety of AZD0120 versus standard regimens (DKd \[daratumumab, carfilzomib, and dexamethaso...

Gilbert, AZPHASE3508 participantsAstraZeneca

View Study Details

NCT06581328Recruiting

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this stud...

Gilbert, AZPHASE4400 participantsTakeda

View Study Details

NCT02343042Recruiting

Selinexor and Backbone Treatments of Multiple Myeloma Patients

This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of patients with relapsed/re...

Gilbert, AZPHASE1300 participantsKaryopharm Therapeutics Inc

View Study Details

NCT06297226Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple myeloma....

Gilbert, AZPHASE2230 participantsJuno Therapeutics, Inc., a Bristol-Myers Squibb Company

View Study Details

NCT07266441Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate how well JNJ-79635322 works (efficacy) in participants with Relapsed or Refractory Multiple Myeloma (RRMM; a cancer that forms in a type of white blood cells c...

Gilbert, AZPHASE2157 participantsJanssen Research & Development, LLC

View Study Details

NCT06433947Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

Phase 1b, open-label study evaluating the safety, tolerability, pharmacokinetics, preliminary antitumor activity, and pharmacodynamics of OPN-6602 monotherapy and in combination with dexamethasone in ...

Gilbert, AZPHASE1130 participantsOpna Bio LLC

View Study Details

NCT07280013Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

The main purpose of the study is to understand the safety and tolerability of cemsidomide when given along with elranatamab in subjects with relapsed or refractory multiple myeloma. The first part of...

Gilbert, AZPHASE160 participantsC4 Therapeutics, Inc.

View Study Details

About Multiple Myeloma Clinical Trials in Gilbert

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 9 multiple myeloma clinical trials recruiting participants in Gilbert, AZ. These studies are seeking a combined 4,575 participants. Research is being sponsored by Janssen Research & Development, LLC, M.D. Anderson Cancer Center, AstraZeneca and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Gilbert — FAQ

Are there multiple myeloma clinical trials in Gilbert?

Yes, there are 9 multiple myeloma clinical trials currently recruiting in Gilbert, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Gilbert?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you about next steps.

Are clinical trials in Gilbert free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gilbert studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 9 active trials in Gilbert are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated July 20, 2026 from ClinicalTrials.gov